Modesto-Lowe Vania, Yelunina Larisa, Hanjan Kawal
Connecticut Valley Hospital, Middletown, CT 06457, USA.
Clin Pediatr (Phila). 2011 Jun;50(6):518-24. doi: 10.1177/0009922810394836. Epub 2011 Jan 23.
Children with attention-deficit/hyperactivity disorder (ADHD) present a concern across clinical, academic, and social domains. However, a subset of these children does fairly well symptomatically and functionally. This article employs a resilience framework to organize the research on factors that promote favorable outcomes in ADHD. A PubMed search was conducted using key words: resilience and ADHD. Of particular interest were articles focusing on modifiable protective factors, such as parenting and pharmacotherapy. There is consensus that genetics strongly contributes to the etiology of ADHD. Parental, peer, and environmental factors may interact with genes to moderate the developmental expression of ADHD. Pharmacotherapy research reveals that medications exert positive effects of modest magnitude in academic achievement, social functioning and quality of life. However, there is insufficient evidence to determine whether treatment can modify developmental outcomes. Efforts to strengthen family support along with access to health and educational resources may also optimize outcomes.
患有注意力缺陷多动障碍(ADHD)的儿童在临床、学业和社交领域都令人担忧。然而,这些儿童中有一部分在症状和功能方面表现相当良好。本文采用复原力框架来组织关于促进ADHD良好结局的因素的研究。使用关键词“复原力”和“ADHD”在PubMed上进行了搜索。特别感兴趣的是关注可改变的保护因素的文章,如育儿和药物治疗。人们一致认为,遗传因素在很大程度上导致了ADHD的病因。父母、同伴和环境因素可能与基因相互作用,以调节ADHD的发育表现。药物治疗研究表明,药物在学业成绩、社交功能和生活质量方面产生适度的积极影响。然而,没有足够的证据来确定治疗是否能改变发育结局。加强家庭支持以及获得健康和教育资源的努力也可能优化结局。